Improved outcomes of ABO incompatible living donor liver transplant with biologically related donors.

Priya Ranjan Nishant Pathak Subhash Gupta Shaleen Agarwal

Published in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024)

ABO-I LDLT is an effective and safe method for increasing the donor pool in absence of ABO-C liver donor. Long term outcomes of recipients with biologically-related donors are marginally better than biologically-unrelated ABO-I LDLT recipient. However, incidence of antibody-mediated graft rejection and biliary complications are more in biologically-unrelated ABO-I liver recipient.

Keyphrases

risk factors
kidney transplantation
type diabetes
adipose tissue
metabolic syndrome
skeletal muscle
drug induced